The idea that there is a chemical etiology of schizophrenia is certainly not a recent development. Kety in his com prehensive review of the subject (74) pointed out that the Hippocratic School viewed mental illness as related to an alteration in blood composition and brain humors. Indeed, Hippocrates was the first to emphasize natural rather than demonic influence in causing certain types of men tal aberration. Thus, as early as 400 B.C. a biological humoral factor responsible for mental illness, a psychotoxin, was postulated.
Richter (112) points out that although the Galenic doctrine of temperaments was teleological in the sense that it con ceived of all things as being made by God for a particular purpose, it was certainly more closely aligned with the organic theories of psychoses. Galen (circa 150 A.D.) described the nine temperaments as being due to mixtures of the various body humors. A perfect temperament was characterized by exact physical symmetry. Richter states that, "The Galenic theory of temperament not only constituted a general theory of disease causation but also attempted to explain individual differences in behaviour." Un fortunately, Galen's theories were based upon the supposition that in order to completely understand man one must first know God's will. This concept, accepted by Galen's followers, only served to limit further scientific enquiry. Singer (122) states that, "After Galen there is a thousand years of darkness, and both medicine and biology almost cease to have a history."
The darkness lasted much longer than a thousand years in the scientific study of mental illness. For it was not until the nineteenth century that man once again suspected that these mental aberrations might have an organic cause. Esquirol in 1816 (29) , attempting to correlate physi cal status and mental disease, noted that the 'lymphatic' individual had a tendency towards chronic psychosis. Moreau (102) associated hashish intoxication with men tal illness, and Morel (103) , the psychi atrist responsible for the term 'dementia praecox', likewise considered the close similarities between intoxication and men tal abnormalities.
The dawn of the modern period in the scientific study of mental disease was signalled in 1864 by Thudicum (132) who is considered the founder of modern neurochemistry, when he wrote, "Many forms of insanity are unquestionably ex ternal manifestations of the effects upon the brain substance of poisons fermented within the body. . . . These poisons we shall, I have no doubt, be able to isolate after we know the normal chemistry to its uttermost detail. And then will come in their turn the crowning discoveries to which our efforts must ultimately be directed, the discovery of the antidotes to poisons and to the fermenting causes and processes which produce them." As Kety (74) points out, Thudicum's beliefs still hold true in regard to current chemical concepts of psychosis.
Three of the founders of modern psy chiatry were at one time exponents of the chemical basis for dementia praecox: Kraepelin, Freud, and Bleuler. Kraepelin (77) stated that, "... a series of facts in dementia praecox up to a certain degree makes probable the existence of an auto intoxication in consequence of a disorder of metabolism." Although he considered schizophrenia a thought disorder, com prising a lack of or inappropriate feeling, Freud saw the possibility that a bio chemical etiology might some day be found. These feelings were expressed in a postcard to Schilder in the early 1920's (41) . Bleuler (20) wrote, "One must acknowledge that at least the great ma jority of clinical pictures which are now collected under the name of dementia praecox, rest on some toxic action or anatomic process which arises indepen dently of psychic influences."
On the basis of clinical observation Carl Jung proposed in 1906 that the psy chological mechanism of dementia prae cox, like hysteria, developed in the pre sence of a 'poisoned' brain. He postulated the existence of a 'toxin-X' which was thought of as a nerve poison generated by the conflict of emotions. Hoffer and Osmond (65) point out that the signifi cance of this hypothesis lies in the fact that the studies on adrenaline and emotion were not published until 1929 and state that Jung's refusal to abandon his 'toxin-X' hypothesis led to his break with Freud. As must be obvious, this entire concept was purely hypothetical. Jung (72) has indicated that his chemical theory of psychosis was based upon the process or 'psychological elimination' rather than specific chemical research: "To make myself clear, I consider the etiology of schizophrenia to be a dual one, namely, up to a certain extent psy chology is indispensable to explain the nature and causes of the initial emotions which give rise to metabolic alterations."
The chemical theories of schizophrenia since 'toxin-X' can be divided roughly .into two categories: a) those proposing the existence of exotoxins, produced by invading parasites; and b) those propos ing an endogenous psychotoxin. The former school of thought flourished for some time. Lowenstein (87) reported the isolation of specific bacilli in cultures from schizophrenic patients. Papez and Bateman (106) , and Rosenow (116) also considered this idea tenable, except that the latter believed the specific etiology to be a streptococcal infection which caused an allergic response in the central ner vous system. Among the attempts to re concile both the exo-and endotoxin theories was that of Buscaino (26) who suggested the production of an endotoxin in the bowel, possibly due to aberration of the gastrointestinal flora, leading to liver damage, which in turn affected the central nervous system leading to the psychological changes. As Kety points out (74) most, if not all, of these findings are merely secondary complications of the chronic institutionalization of the patients studied.
The search for endogenously produced psychotoxins responsible for the schizo phrenic state has proceeded along two distinct avenues: a), attempts to discover abnormalities in intermediate metabolic pathways; and b) attempts to isolate an abnormal metabolite in the body fluids of schizophrenic patients. Both methods have as their eventual goal the discovery of a means to prevent the formation of this psychotoxin. As in the introduction of new therapeutic measures for the treatment of the disorder, research into its etiology has proceeded primarily along empirical rather than purely theoretical grounds. The areas of study have been diverse, and virtually all of this work has been crowded into the last 30 to 40 years. Thus, instead of attempting to review the developments chronologically, per haps it would be better to consider each area independently.
As early as 1925 Bowman and Fry (23) reported a decrease in basal metabolism in schizophrenics, whereas as recently as 1955 a decrease in cerebral metabolism has been suggested (56) . A later study, however, has failed to confirm these findings (38) . Freeman (39) and Hoskins (71) found a generalized tendency towards deficient oxidative processes.
Several groups have reported an abnor mal glucose tolerance in schizophrenia (40, 89) . In 1954 Walaas et al. (135) claimed that sera from schizophrenic patients had the ability to stimulate glu cose utilization by the isolated rat dia phragm, whereas Streifler et al. (129) re ported an inhibition of glucose utilization by the rat retina. An increase in the lac tate/pyruvate ratio in chick erythrocytes when incubated with plasma from schizo phrenics has been found by several groups (3, 4, 42, 43) . Both Kety (74) and Freedman (38) have pointed out, however, that all of these positive findings can be ac counted for as secondary complications of hepatic disease or nutritional deficien cies in the patients being studied. Indeed, Horwitt et al. (69) demonstrated that such abnormalities in an institutionalized population, such as that studied in the experiments cited above, could be avoided by the administration of the B-group vitamins.
Several people have suggested endo crine disorders as the primary cause of schizophrenia. Because practically every hormone has at one time or another been implicated in this respect, it is proposed to discuss these hypotheses only super ficially. In 1900 Sir David Bruce adminis tered thyroid extract to schizophrenic patients and claimed that this had a bene ficial effect (24) ; others (22, 70) have also implicated thyroid dysfunction in this regard. Altschule et al. (3) found the adrenal cortex to be specifically un responsive in schizophrenics, whereas Bliss et al. (21) found the adrenocortical reactivity of chronic schizophrenics to be equal to that of normals, and concluded that there is no evidence for impairment of adrenocortical function in schizo phrenia.
Abnormal adrenaline -noradrenaline metabolism has been implicated in ar ticles by Funkenstein (45) .and Elmadjian (28) , but Holland (67) could not detect any difference in the rate of metabolism of the catecholamines in schizophrenics and normal controls. Moreover, Love-grove et al. (86) found no differences in the 24-hour excretion of adrenaline, nora drenaline or 17-hydroxycorticosteroids. Marrazzi (96) found chat cerebral synap tic transmission could be inhibited by adrenaline, noradrenaline and serotonin. Thus, he suggested that schizophrenia might be the consequence of an imbalance in the normal concentration of the catecholamines at central synapses. It was claimed in 1958 (136) that sera from schizophrenics was capable of abolishing or reversing the systemic vasopressor response caused by the topical application of adrenaline to the exposed cerebral cor tex of a rabbit, while normal sera had no effect. This finding was corroborated in 1960 by Minz and Walaszek (101) ; they also found no change in vasopressor response following the application of sera from normal subjects, from pregnant women, and from patients with various organic diseases. It is perhaps significant to note that in a total of 68 rabbits which had been pretreated with 'schizophrenic' serum, the effects of adrenaline were abolished in 21, reversed in 18, whereas in 18 the effects were no different from normal, and the remaining 11 were men tioned to have shown a 'slight' hyperten sive response. Gerard (50) , however, was unable to verify these results. Gal (47) reported an increase in the cholinesterase concentration of blood from schizo phrenics.
Several attempts have been made to develop comprehensive theories concern ing the etiology of schizophrenia. While a number of these have received wide support for a number of years, none is completely tenable. The adrenochrome hypothesis of the Saskatchewan group represents one such attempt (105) . In 1952 Osmond and Smythies, later joined by Hoffer, were impressed by the role of the adrenals in schizophrenia and with the structural similarity between adren aline and mescaline (a psychotomimetic). At that time they hypothesized the existence of an 'M-substance', a specific metabolic intermediate which was thought to be responsible for the schizo phrenic state. This was thought to be a methylation product of noradrenaline, most probably an adrenochrome (66) . The same group reported in 1954 (62) that the intravenous injection of adreno chrome produced visual hallucinations in four normal volunteers. Hoffer (65) re marked that "Dr. Osmond noted changes in thought, apathy, uncertainty, and I noted in him (one of the volunteers studied) a marked change in personality which I had not witnessed before or since." The adrenochrome hypothesis stated that faulty catecholamine meta bolism was the primary biochemical de fect in schizophrenia and that the symp toms associated with the disorder are due to the psychotoxic properties of an adrenaline derivative, probably adreno chrome or adrenolutin, both of which they considered to be hallucinogenic. Smythies (124) later retracted his sup port of this theory. In a recent review of the subject Hoffer (66) concluded that current research supports both premises upon which the adrenochrome-adrenolutin theory is based: that adrenochrome is a psychotomimetic, and that its presence in the body is related in time to the symptoms of the disease; and that,". . . .It now seems to be only a matter of time before the adrenochrome theory is ac cepted as one useful biochemical ex planation for schizophrenia." Witt (138) demonstrated that adreno chrome, mescaline, and lysergic acid diethylamide (LSD) were all active in inhibiting the construction of the normal spider web. The group working at Tulane (81) reported a speed-up in the in vitro oxidation of adrenaline in the presence of schizophrenic plasma as compared to nor mal, and that ceruloplasmin was the oxidizing agent responsible for this ac tivity. They claimed to have found an increased level of ceruloplasmin in the blood of schizophrenics. Hoffer and Kenyon (63) cited evidence that adrenol utin was the compound formed from adrenaline, although the enzyme system responsible for this conversion had not yet been found, nor had either adreno chrome or adrenolutin ever been detected in vivo. In 1958 however, Hoffer (64) stated that he had been able to detect adrenochrome in normal plasma at a concentration of 50 microgm./L. and that this concentration was greatly increased upon the administration of LSD. Shortly afterward, Szara et al. (130) described a specific test for adrenochrome which could detect amounts as small as 20 microgm./L. but they were unable to detect any adrenochrome in a total of 17 different plasma samples, including 11 from schizophrenics. Similar negative findings have been reported by Schwartz et al. (117) .
A number of other studies have been conducted which have made obsolete any hypothesis concerning the in vivo oxida tion of catecholamines to adrenochrome. Shayer and Smiley (120), using radio active metabolites, determined that adre nochrome was not a breakdown product of adrenaline. In 1957 Armstrong's group reported (7) that 3-methoxy-4-hydroxymandelic acid (VMA) was a major metabolite of noradrenaline. Axelrod et al. (8) demonstrated that the principal catabolic pathway of adrenaline is through O-methylation to metanephrine, which in turn undergoes oxidative deamination by monoamine oxidase to produce VMA.
Mann and Quastel suggested in 1940 (93) that a toxic amine might be re sponsible for schizophrenia, whereas Proptopopov (110) went a step further by stating that a congenital defect makes the schizophrenic susceptible to toxins produced by faulty protein metabolism. In his study of nitrogen metabolism in periodic catatonia Gjessing (54) sug gested the possibility of a relationship between intermediary protein metabolism and schizophrenia. Many groups have re ported the existence of unusual plasma proteins in schizophrenics (42, 44, 57, 78, 108) ; however, as Kety pointed out (74), many of these studies have failed to con-trol dietary and other important factors in the patients.
In 1951 Young demonstrated the pre sence of an abnormal indole in schizo phrenic urine which was thought to be a tryptophan derivative (141) . Two major discoveries implicated serotonin as being the abnormal metabolite. First of all, Gaddum in 1953 (46) showed that the smooth muscle constrictor effect of sero tonin could be antagonized by a minute amount of LSD. Amin et al. (5) isolated serotonin from brain tissue of the dog, the highest levels being in the limbic sys tem, and noted that it was closely related structurally to LSD. Shortly afterward Gaddum was quoted as having said (46), ". . . It is possible that HT (serotonin) in our brains plays an essential part in keep ing us sane," and that, "the effect of LSD is due to its inhibitory action on the HT in the brain." In 1954 Wooley and Shaw (139) proposed their serotonin hypo thesis which suggested that schizophrenia might be the result of a metabolic failure leading to a cerebral serotonin deficiency. They stated that, "The demonstrated ability of such agents (LSD) to antagon ize the action of serotonin in smooth muscle, and the finding of serotonin in the brain suggest that the mental changes caused by the drugs (the psychotomime tics) are the result of a serotonin de ficiency which they induce in the brain." Others (95) suggested that an excess of brain serotonin was the causative factor in schizophrenia. Bulle and Konchegul (25) concluded that a neurohumor with neurotrophic properties identical to sero tonin was involved in the pathogenesis of schizophrenia as a result of their work on cerebrospinal fluid from schizo phrenics, which was said to produce iden tical neurological and autonomic reflex changes in the dog as that produced by serotonin and LSD after their intra arterial administration.
There are a number of inconsistencies in the serotonin hypothesis. It was pointed out in 1959 (33) that there is no difference in the mean concentration of blood sero tonin in normal, chronic, and acute schizophrenics and thus no metabolic defect in tryptophan metabolism is indi cated. Kety (74) mentioned a number of points which tend to negate this hypo thesis: a) some LSD derivatives, which have anti-serotonin activity, have no effect on behaviour; b) iproniazid does not inhibit brain serotonin, and yet it causes behavioural changes; and c) the phenothiazine-type tranquillizers have no effect on brain serotonin. However, Kety did express the feeling that, "It seems reasonable to conclude that serotonin as well as norepinephrine in the brain have some important functions there, and the evidence in general supports this thesis, even though it also suggests that their roles still remain to be defined."
The interest in ceruloplasmin was sparked by Akerfeldt's discovery in 1956 (2) of what was considered to be a specific test for schizophrenia; it de pended upon the oxidation of N,Ndimethyl-p-phenylenediamine by cerulo plasmin, an alpha-2 globulin serving to transport copper in the blood. It had previously been shown that ceruloplas min was capable of oxidizing a number of different substances including phenylenediamine and adrenaline (68, 81, 82) , and that in schizophrenia, as in pregnancy and a large number of organic diseases, there is a great increase in blood copper, almost all in the form of ceruloplasmin (1, 75, 94) . Another group (140) re ported that they could detect an increase in both plasma copper and ceruloplasmin early in the disease, but not in the chronic state. Bakwin et al. (9) claimed that children from 5 to 17 years of age have a significantly higher level of serum copper than normal adults, but no dif ference was found between the copper levels of schizophrenic and normal children. Melander et al. (100) concluded that ceruloplasmin was a product of mental stress which may decrease or negate the influence of the psychotoxic substance in schizophrenic blood. This conclusion was based upon a study which Vol. 12, No. 2 showed that ceruloplasmin was capable of decreasing the toxicity of a number of psychically-active drugs, including chlorpromazine, nicotine, and strychnine.
A much more highly-controlled study of ceruloplasmin concentration was per formed by McDonald in 1957 (88) in which three different groups of schizo phrenic patients were used: one from the National Institute of A'lental Health in Bethesda, Md., maintained on a speciallycontrolled diet, and the other two groups from state hospitals. Using a more sophis ticated adaptation of the Akerfeldt test, he was unable to detect an increase in ceruloplasmin or serum copper in any of the groups tested. The ascorbic acid levels were low in the state hospital patients and in one group of controls and the Aker feldt test came out positive. In the patients from the NIMH, however, ascorbic acid levels were normal and the Akerfeldt test proved negative. Another group (140) also came to the conclusion that the Aker feldt test was unreliable as a diagnostic agent as it was too closely correlated with the ascorbic acid level of the plasma, a factor too easily influenced by both diet and disease.
The work, which has previously been cited, of the Tulane group under the direction of Heath, stemmed from studies on the comparative rates of oxidation of adrenaline by schizophrenic and normal serum. In an attempt to isolate the enzyme responsible for this oxidation, which they suspected was ceruloplasmin, serum frac tionation studies were undertaken (81) . After making certain improvements on the initial fractionation technique, they were able to isolate a fraction from schizophrenic serum which was separate from most of the ceruloplasmin. This substance, which was named 'taraxein' (from the Greek root tar ossein, meaning 'to disturb'), was administered to mon keys, to 17 non-psychotics, and to one schizophrenic in remission (59) . In each case the injection of 'taraxein' caused the development of what they described as 'schizophrenic-like symptoms'. At that time it was concluded that the data ten tatively suggested that schizophrenia might be a single disease entity despite diverse symptomatology. Lief (85) studied the effect of 'taraxein' adminis tered to a resident in psychiatry who was concurrently undergoing analysis. The psychological effects were described as being identical to those which Bleuler had identified as the primary symptoms of schizophrenia, including blocking of thought processes, autism, body es trangement, and flattening of affect. Al though Lief felt that this subject was a better interpreter of his subjective feel ings than the prisoner volunteers used by Heath, it is perhaps significant to note that this was not conducted as a double-blind study: both the subject and the observer were aware of the nature of the substance injected. Kety (74) pointed out chat there are several dis crepancies in the reports of both the subject and the observer. A later study by the Tulane group (60) expanded their previous observation of the devel opment of schizophrenic-like symptoms in normal individuals upon the admin istration of 'taraxein', so that they were able to state that the symptoms pro duced were unlike those caused by the psychotomimetics. They also indicated that 'taraxein' could not be isolated from the blood of normal individuals. A number of other groups (97,98,99) using Heath's technique for obtaining 'taraxein' have confirmed these findings in a number of different species.
In an article reviewing his findings .to 1961, Heath (61) pointed out that 'taraxein' is a serum protein, either a beta or gamma globulin, which is very unstable. In fact, Heath accounts for the failure of others to duplicate his work, vide infra, as being due to the instability of the protein factor. Although he ad mits that this is a 'diffuse' concept, Heath considers 'taraxein' to be the biochemical manifestation of an inborn error in metabolism, and suggests that it acts specifically either to interfere with the enzyme activity of brain amines, or to alter the permeability of the blood-brain barrier, thus allowing the entrance of endotoxins.
A number of groups have been unable to confirm Heath's basic premise that 'taraxein' is a psychotoxin producing schizophrenic-like symptoms in normal individuals. Robins et al. (115) processed schizophrenic serum in their own labora tory following the Tulane procedure, and were unable to duplicate the findings of the Tulane group. In a total of 20 sub jects receiving 'taraxein' only five de veloped even slight behavioural distur bances. In fact, physiological saline in jections produced the same frequency of these behavioural disturbances as the plasma factions isolated from 'schizo phrenic' blood. Samples of 'taraxein' shipped to Robins in St. Louis by Heath also proved to be inactive. As Kety so aptly mentioned (74) , even if the frac tions injected were not 'taraxein' this does not invalidate the finding that psychotic symptoms can be produced by saline and normal blood. Two other.failures to con firm the results of the Tulane group have been reported (53, 121) . The latter group has expressed the opinion that the failure of any independent laboratory, not re lated to Heath's group, to confirm these observations lays open to question the validity of the results. They concluded that 'taraxein' is an artifact. Kety (74) summed up the situation regarding 'taraxein' quite concisely when he stated: "The possibility, remote as it may be, that the reported effects of 'taraxein' are the result of a combination of suggestion, non-specific toxic reactions from am monium sulfate or other contaminants and reinforcements of these cues by the unconscious biases of subject and obser ver through the device of an unstructural interview, is one which has not been ruled out."
The second major approach to study ing the biochemical etiology of schizo phrenia has been attempts to discover psychotoxic factors in the body fluids of schizophrenics with the hope of being able to isolate the abnormal metabolite(s) responsible for this action. In a sense this is a more logical approach, for the entire rationale behind the study of the bio chemistry of the disorder is that an ab normal metabolite having this action exists. If this be the case, then it should be possible to cause toxic reactions in living cells by introducing samples of body fluids containing this factor. This approach to the problem has been at tempted with most of the human body fluids. Baruk and Camus (10) reported at the Second International Congress of Psy chiatry in 1957, that schizophrenic bile caused a form of disinterest and indif ference in pigeons which they described as catatonic-like. Another group (79) claimed to have duplicated this result using bile from two catatonics, and five epileptics. Study of schizophrenic cere brospinal fluid (C.S.F.) was first con ducted in 1932 by Gamper et al. (48) , when they injected schizophrenic C.S.F. into the anterior chamber of the eyes of rabbits and discovered that this led to marked inflammatory changes which could not be duplicated by using normal C.S.F. Reiter (111) , however, could not confirm this finding. In 1933 Gamper and Krai (49) reported that schizophrenic C.S.F. increased the mortality rate of mice when injected into the subarachnoid space, with the major degenerative changes discovered at autopsy occurring in the brain and liver. It was later stated by Le Grande and Annee (83) that the subcutaneous injection of schizophrenic C.S.F. which had first been evaporated, then redissolved, produced catatonic symptoms in rats: the rats were described as being apathetic, listless, having de creased spontaneous activity, and some times assuming catatonic postures. This study, however, was conducted on only 13 rats, and three of these failed to show the above reaction. Shapiro (119) , using a more quantitative approach, was unable to demonstrate a catatogenic agent in catatonic C.S.F. Employing an activity wheel, he reported that the performance of the rats was related to the hypertonicity of the solutions injected. Schizo phrenic C.S.F. was found to be non-toxic to strain L cells in tissue culture (31) .
Rieder discovered in 1957 (113) that extracts from schizophrenic urine when fed to spiders led to impairment of web quality. Two groups (90, 133) have re ported that the intracisternal injection into monkeys of a urinary extract from schizophrenic patients brought about behavioural and electroencephalographic changes. Another worker (73) found that applying a urinary extract from schizo phrenics to the cortex of an unanesthetized rabbit led to epileptiform seizure patterns in the EEG. German and Kemali (52) repeated this work on rats and claimed the same result.
By far the greatest amount of work done on schizophrenic body fluids has been conducted using blood samples. Lazell and Prince (80) in 1929 were the first to demonstrate the toxicity of schizo phrenic serum on tadpoles (Rana catsbiam). Other findings of schizophrenic blood samples having a toxic effect on larval forms have been reported (35, 92) . Being unable to duplicate these results, Edisen (27) pointed out the high spon taneous death rate of larval forms, and criticized the unreliability and generality of the method. Schwarzenbach (118) found that schizophrenic serum inhibited spore germination. Schizophrenic serum was also found to affect the behaviour and web-formation of the spider Zilla-xnotata (11) .
In 1936 Wahlstrom (134) found that the injection of 1 ml. of schizophrenic serum intraperitoneally into white mice led to a mortality rate of 30 per cent, while the rate for normal serum was 9.8 per cent. Sjovall (123) , however, who found that serum heated for 30 minutes prior to being injected lost its toxicity, criticized Wahlstrom's work on the grounds that he used too few experimen tal units. Fedoroff (30) in studying the effects of human blood serum on tissue cultures found that schizophrenic blood serum was very toxic to strain L cells. This toxicity was attributed to nondialyzable, heat-stable and heat-labile substances. Fedoroff, like Wahlstrom, found the heat-labile substance to be in activated by heating the serum at 50°C for 30 minutes, while the heat-stable sub stance could be absorbed by either living or dead strain L cells. In addition, he dis covered that the introduction of non toxic human serum (from normal donors) into serum inactivated by heating re stored the activity of the latter. It was later determined (32) that probably all human sera contain the heat-labile sub stance, but the type and number of heatstable substances varies from one in dividual to another.
Rizzolo (114) showed that schizo phrenic serum initially increased the ex citability of nervous tissue (Calinectus sapidus, the blue crab), followed by alternating periods of increased and de creased excitability. Another group (14) was able to elicit changes in the potential of the optic nerves of rabbits upon the administration of plasma globulins de rived from schizophrenic blood; while German (51) evoked cortical potential changes in rats when schizophrenic serum was applied topically to the cortex. Using micro-electrodes implanted 200 to 400 microns beneath the pial surface, German reported a marked enhancement in the amplitude of the negative component of the cortical response (in terms of per cent of control rate): from a base-line level of 100, schizophrenic serum in creased the cortical potential to 230 within 25 minutes after application, whereas the control groups yielded a value of 125. He concluded: "It is sug gested that increases in the amplitude of cortical-evoked responses produced by schizophrenic sera may be significant in understanding the pathological physiol ogy of the disease."
Reasoning that if there exists a psycho toxin in schizophrenic blood, then ex change of that blood might lead to improvement in the patient, several groups have attempted exchange transfu sions of normal for schizophrenic blood. One of the first such attempts was made in 1925 (107) when whole blood from normal individuals was administered intramuscularly to six schizophrenic patients, with the result that five were thought to have shown 'improvement' in their behaviour. Goldblatt and Krapiwkin (55) gave a single transfusion of blood from normals or schizophrenics in remis sion to 12 schizophrenics and claimed that three had complete remission, while eight demonstrated some improvement. In 1938 Reiter (111) performed an ex change transfusion between four schizo phrenics and four non-psychotic volun teers and reported that three patients had temporary remission for up to three or four weeks. In 1957 Freedman and Gins berg (36) described an exchange trans fusion which they performed utilizing a set of identical twins who were both schizophrenics. One of the pair acted as a control, while the other had approxi mately 55. per cent of his blood volume exchanged with a non-psychotic volun teer. The authors claimed that from an initial state,of restlessness the patient be came tranquil, more socially conscious, and that, "He became more aware of his surroundings in succeeding days, at tempted to play simple games, showed evidence of affection towards others . . . and began to babble." The duration of improvement was stated to have lasted for three weeks, with the patient revert ing to his former state by the fifth week. No change in the control twin was ob served.
Several groups performing blood ex changes were unable to duplicate these results. In 1958 Freedman and Ginsberg (37) described such an experiment in which there was no change in the condi tion of four chronic schizophrenic adults, and only equivocal improvement in a child. This result was in addition to their failure to ameliorate the abnormal be haviour of three chronic schizophrenics in the experiment they had conducted the previous year. Another group (104) in a cross-transfusion experiment between schizophrenic adults and normal volunters was unable to find any changes in the behaviour of the normals either dur ing or after the transfusion, whereas the schizophrenics became increasingly dis turbed psychiatrically during the 24-hour period after the transfusion.
Heath et al. (59) reported a reversal of the above procedure: in their experi ment they rapidly exchanged a total of 450 ml. of schizophrenic plasma in each of four non-psychotic volunteers. All four of the volunteers were described as exhibiting mild schizophrenic symptoms which lasted from 15 to 45 minutes. This report has stimulated a great deal of work along these lines. The determination of the psychotomimetic properties of samples of blood from psychotics has, however, proved to be far too subjective in human studies; thus, several of the recently devised experimental psycho logical techniques utilizing animals, have been applied to the problem. Although one must always be cautious in extra polating behavioural studies from animals to man, there are obvious advantages to be gained, primarily because it is easier to evoke a single desired response from an animal. As Liberson has pointed out (84) many psychiatrists express doubts concerning the value of animal experi mentation in contributing to the knowl edge of the human mind and behaviour. He concluded:
"Obviously, there is little to be learned from animal studies in so far as the con tent of human conflicts is concerned, or in regard to the complexities and richness of human interpersonal and socio-economic relationships. It re mains true, however, that fundamental biological processes related to anxiety, fear, avoidance, gratification, motiva tion, submissiveness, aggressiveness and Vol. 12, No. 2 learning, may be studied in animals with a reasonable probability that such studies may shed some light on outunderstanding of the corresponding processes in man." One of the first attempts to quantitate the effects on the behaviour of the rat of injecting various plasma samples was made by Winter and Flataker in 1957 (137) , by means of a rope-climbing ex periment. It was reported that the intra peritoneal injection of one ml. of plasma from psychotic patients, including schizo phrenics, produced a state comparable to that caused by an LSD injection. They compared the effects of plasma injection from 80 psychotic and 82 non-psychotic individuals on the ability of trained rats to climb a rope for a food reward and claimed that the mean climbing time was significantly greater in the rats receiving the psychotic plasma. The injection of smaller quantities (0.5 ml.) had no effect. The authors concluded: "There appears to be a toxic factor in the plasma of schizophrenics and of other psychotics, but there is no assurance that it is identical in all cases."
A group at the Worcester Foundation (12) claimed to have confirmed Winter and Flataker's results and expanded their study. They found increases in climbing time delay (CTD) in trained rats to which blood plasma and plasma proteins from non-psychotic, and acute and chronic schizophrenics had been adminis tered; however, the effect was signifi cantly greater with the samples from the psychotic patients, the increase in CTD occurring within minutes after injection and reaching a maximum within an hour. It was claimed that these results demon strated the presence of a factor (s) in human plasma affecting learned be havioural patterns in rats, and although this factor was present in normal plasma, it was present in larger concentrations in schizophrenics. Although the authors cautioned that, "The active principle may simply be a concomitant of the emo tionally disturbed condition of the patients . . . not necessarily related to psychoses per se," they felt more inclined to the view of a change being produced in the permeability of the blood-brain barrier, allowing the entrance of a toxin into the central nervous system. A plasma globulin was later isolated from human blood which contained a labile factor claimed to have produced behavioural changes in rats (13) . This lability was said to be related to oxidative processes which were retarded or reversed when the fraction was kept under an atmos phere of hydrogen. Further studies along this line have been reported by Bergen's group (15, 16, 17) .
Neither Kornetsky (76) nor Gowdey and Lovegrove (58) were able to dupli cate the results of Bergen et al. Ghent and Freedman (53) concluded that there was no evidence for a psychotoxic substance in the blood of schizophrenics, but con ceived of the possibility that since Winter and Flataker's patients had not been removed from ataractic therapy this might have accounted for their re sults. Their study, however, failed to differentiate between the effects of nor mal and schizophrenic plasma, even when the schizophrenics had been on heavy doses of chlorpromazine for several weeks. Kety (74) , with good reason, criticized the rope-climbing method as a measure of behaviour because it is more affected by alterations in motor ability than by changes in behaviour. Indeed, this procedure was originally devised in 1943 by Macht (91) as a means of testing ergographic capacity of rats.
More sophisticated behavioural studies have been conducted by several groups. Stern et al. (127) found in studying the competition for food, and learned and visual discrimination, that schizophrenic plasma produced a significantly greater effect on behaviour in rats than normal plasma. A Russian worker, Poliakova (109) found that blood from depressive psychotics increased the time necessary for a dog to negotiate a maze for a food reward. Ferguson and Fisher (34) re-ported that the injection of schizophrenic serum and plasma significantly increased the precision timing behaviour in Cebus monkeys.
Among the groups unable to differ entiate between the effects of normal and schizophrenic blood was Stern et al. (126) studying two measures of activity in the rat: open field behaviour, and activity wheel running. They found a general depression of activity in all rats injected with plasma samples, regardless of whether the blood came from psycho tics or apparent normals, and con cluded, "At least part of the effect ob served by these authors (Winter and Flataker) was a function of a decrease in the activity levels of experimentally in jected animals." Using operant condi tioning methods, Anger (6), with a con tinuous reinforcement schedule, and Gowdey and Lovegrove (58) , with a fixed-ratio program, were also unable to detect any differnce between the various types of plasma.
Reasoning that one of the primary manifestations of schizophrenia is an 'adaptational breakdown', that is an im pairment in the ability to adapt to dif ferent situations successfully, Bishop (18) studied the effects of schizophrenic plasma on learning ability in the rat. He pointed out that the schizophrenic is usually able to perform simple, highlyoverlearned motor responses, as these are not as greatly impaired as the ability to learn new responses. Using instrumental avoidance conditioning, Bishop found that the intraperitoneal injection of 1.0 ml. of schizophrenic plasma per 100 gin. body weight of the rat, caused significant impairment of learning compared to both normal plasma and saline. There was no effect, however, from either of the two types of plasma on animals already con ditioned to the point of overlearning. Bishop concluded that there appeared to be a substance in schizophrenic plasma which causes impairment of adaptive learning. These findings were repeated and elaborated upon in a later study (19) .
We (131) were not able to confirm these findings. Fresh plasma from chronic schizophrenic patients had no more effect on the rate of acquisition of a conditioned avoidance task by untrained rats than that of plasma from apparently normal subjects. Groups of rats injected with an equal volume of saline learned more quickly than either of the groups injected with plasma. Stewart and Irvine (128) were also unable to discover any signi ficant effect of schizophrenic plasma upon the acquisition of the conditioned avoidance response.
In his careful review of the study of the biochemistry of mental disease, Sourkes (125) pointed out that although some interesting discoveries have been made, no specific metabolic error in schizo phrenia has yet been demonstrated. He classified the findings in this field of study into three categories: a) the original findings have been discontinued; b) they have been attributed to some extraneous factor, completely unrelated to the primary disorder; or c) the results re ported have been verified, but are not specific for the disorder. As recently as December, 1965, Brodie is quoted (Schmeck, H. M., New York Times, Dec. 31, 1965) as telling the American Association for the Advancement of Science: "Despite a decade or more of biochemical investigation and a plethora of reported biochemical abnormalities, the fact remains that not a single bio chemical defect in mental disease has been established."
Summary
The concept of a chemical cause of schizophrenia is as old as the Hippocratic School. The idea gained favour after Thudicum postulated that insanity was caused by poisons fermented within the body and that chemical studies could isolate the poisons and discover antidotes. Research with chemical compounds capable of inducing 'experimental psy-choses' led to a revival of interest in the toxic theory, and the development of new biochemical techniques intensified the search for a biochemical lesion in schizo phrenia. Claims that a variety of abnor mal metabolites or unusual amounts of normal metabolites are found in mental patients have been made, including: ad renal corticosteroids, imidazoles, adrenal medullary and other catecholamines, adrenochrome and other possible cate cholamine metabolites, 5-hydroxy tryptamine, various indoles, copper-contain ing compounds (ceruloplasmin) and even histamine. It was also claimed that transfusions of normal blood caused transient improvement of schizophrenics and, conversely, that blood from schizo phrenic patients contained a toxic sub stance which could produce abnormal behaviour in human volunteers, trained monkeys and rats. Toxic effects have been reported following administration of fractions from 'schizophrenic' blood or other body fluids in a variety of bio chemical and physiological procedures and in a variety of organisms; mice, tad poles, crabs, pigeons, spiders, larvae, seeds, molds and fungi. Most of these claims have been disputed: the abnormal substances are not present, or not pre sent in higher concentrations in schizo phrenics, or not capable of inducing measurable behavioural changes.
Appealing as the chemical concept is, no unequivocal, substantiated evidence for it has yet been produced.
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